Researcher
Isabel Leroux-Roels
- Keywords:vaccine immunology, infection prevention, infection control, vaccinology
- Disciplines:Diagnostics, Medicinal products, Laboratory medicine, Bacteriology, Infectious diseases, Vaccinology, Virology
Affiliations
- Department of Diagnostic Sciences (Department)
Member
From1 Oct 2018 → Today - Department of Clinical chemistry, microbiology and immunology (Department)
Member
From1 Nov 2003 → 30 Sep 2018
Projects
1 - 2 of 2
- HIGH-THROUGHPUT, HIGH-SENSITIVITY AND COST-EFFECTIVE MONITORING OF INNATE AND ADAPTIVE IMMUNE RESPONSES AT SINGLE CELL LEVELFrom15 Dec 2022 → TodayFunding: BOF - scientific equipment program
- Rapid ex-vivo detection, quantification and characterisation of cell-mediated immune responses induced by natural infection or vaccination with SARS-CoV-2 orr other pathogens.From1 Apr 2021 → 31 Mar 2023Funding: IOF - technology validation in lab
Publications
11 - 20 of 45
- Implementation of the Infection Risk Scan (IRIS) in nine hospitals in the Belgian-Dutch border region (i-4-1-Health project)(2022)
Authors: M Verelst, I Willemsen, V Weterings, Pascal De Waegemaeker, Isabel Leroux-Roels, E Nieuwkoop, V Saegeman, L van Alphen, S van Kleef-van Koeveringe, M Kluytmans-van den Bergh, et al.
- The role of cell-mediated immunity against influenza and its implications for vaccine evaluation(2022)
Authors: Yorick Janssens, Gwenn Waerlop, Frédéric Clement, Geert Leroux-Roels, Isabel Leroux-Roels
- Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 : a phase 1 randomized clinical trial(2021)
Authors: PG Kremsner, P Mann, A Kroidl, Isabel Leroux-Roels, C Schindler, JJ Gabor, M Schunk, Geert Leroux-Roels, JJ Bosch, R Fendel, et al.
Pages: 931 - 941 - Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT) : a randomised, double-blind, phase 3 trial(2021)
Authors: T Vesikari, JM Langley, N Segall, BJ Ward, C Cooper, G Poliquin, B Smith, S Gantt, JE McElhaney, M Dionne, et al.
Pages: 1271 - 1281 - Immunogenicity and safety of a 3-antigen hepatitis B vaccine vs a single-antigen hepatitis B vaccine : a phase 3 randomized clinical trial(2021)
Authors: T Vesikari, A Finn, P van Damme, Isabel Leroux-Roels, Geert Leroux-Roels, N Segall, A Toma, G Vallieres, R Aronson, D Reich, et al.
- ESBL-producing, carbapenem- and ciprofloxacin-resistant Escherichia coli in Belgian and Dutch broiler and pig farms : a cross-sectional and cross-border study(2021)
Authors: Sien De Koster, Moniek Ringenier, Christine Lammens, Arjan Stegeman, Tijs Tobias, Francisca Velkers, Hans Vernooij, Marjolein Kluytmans-van den Bergh, Jan Kluytmans, Jeroen Dewulf, et al.
- Interim results of a phase 1-2a trial of Ad26.COV2.S Covid-19 vaccine(2021)
Authors: J Sadoff, M Le Gars, G Shukarev, D Heerwegh, C Truyers, AM de Groot, J Stoop, S Tete, W Van Damme, Isabel Leroux-Roels, et al.
Pages: 1824 - 1835 - Comparison of five SARS-CoV-2 rapid antigen detection tests in a hospital setting and performance of one antigen assay in routine practice : a useful tool to guide isolation precautions?(2021)
Authors: E Van Honacker, K Van Vaerenbergh, A Boel, H De Beenhouwer, Isabel Leroux-Roels, L Cattoir
Pages: 144 - 152 - Feedback of ATP measurement as a tool for reducing environmental contamination in hospitals in the Dutch/Belgian border area(2021)
Authors: A Van Arkel, I Willemsen, L Kilsdonk-Bode, S Vlamings-Wagenaars, A Van Oudheusden, Isabel Leroux-Roels, M Verelst, E Maas, A Van Oosten, P Willemse, et al.
- Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers : a phase 1 trial(2021)
Authors: Cassandra Aldrich, Isabel Leroux-Roels, Katell Bidet Huang, Mihai Alexandru Bica, Edde Loeliger, Oliver Schoenborn-Kellenberger, Lisa Walz, Geert Leroux-Roels, Frank von Sonnenburg, Lidia Oostvogels
Pages: 1310 - 1318